Bio-Techne
TECH
528 hedge funds and large institutions have $12.3B invested in Bio-Techne in 2023 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 206 increasing their positions, 189 reducing their positions, and 69 closing their positions.
151% more call options, than puts
Call options by funds: $20.8M | Put options by funds: $8.3M
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
12% more capital invested
Capital invested by funds: $11.1B → $12.3B (+$1.28B)
1.25% more ownership
Funds ownership: 94.76% → 96.01% (+1.3%)
9% more repeat investments, than reductions
Existing positions increased: 206 | Existing positions reduced: 189
4% less funds holding
Funds holding: 549 → 528 (-21)
25% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 69
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$286M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$186M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$105M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$87.6M |
| 5 |
BlackRock
New York
|
+$74.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
-$90.6M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
-$59.5M |
| 3 |
Millennium Management
New York
|
-$59.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$42.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$35.9M |
TECH Hedge Fund Activity: Q2 2023 in Review
528 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2023, worth a combined $12.3B — up 12% from $11.1B a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of TECH and 52 opened new positions — a net loss of 17 holders — while 189 trimmed existing stakes and 206 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $286M. The largest seller was Select Equity Group, cutting an estimated $90.6M.
- 528 institutional investors held Bio-Techne (TECH) as of Q2 2023, down from 549 in Q1 2023.
- Funds reported $12.3B of Bio-Techne stock for Q2 2023, up 12% quarter-over-quarter.
- 52 funds opened new Bio-Techne positions in Q2 2023 and 69 closed out, a net change of -17 holders.
- The largest Bio-Techne buyer in Q2 2023 was T. Rowe Price Associates, an estimated $286M added.
- The largest Bio-Techne seller in Q2 2023 was Select Equity Group, an estimated $90.6M sold.
Based on aggregated 13F filings for Q2 2023.